RECENT FUNDING ROUNDS
| Company | Country | Profile | Funding round | Value | Date | |
|---|---|---|---|---|---|---|
|
Blossomhill Therapeutics Inc | Biotechnology company focused on oncology and autoimmune disorders. | Series A | USD 71,000,000 | ||
|
Cambridge Cancer Genomics Ltd | CCG.ai empowers clinicians to make personalised treatment strategies. | Seed | |||
|
Bioarray Genetics Inc | Personalized oncology startup. | Series B | USD 4,000,000 |
MOST ACTIVE INVESTORS
| Felicis Ventures | US | 2 |
| Connecticut Innovations Inc | US | 1 |
| Global Health Science Fund | 1 | |
| Cormorant Asset Management | 1 | |
| Hercules BioVentures | 1 | |
| OrbiMed Advisors LLC | US | 1 |
| Vivo Capital | 1 | |
| Y Combinator | US | 1 |
BEST FUNDED
Biotechnology company focused on oncology and autoimmune disorders.
CCG.ai empowers clinicians to make personalised treatment strategies.
